http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SG-175463-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5415c38af7441b7fade4b28e7077a74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bc6d7e07cca0c16f01bcf4a891790c0 |
| filingDate | 2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a87de5e2cc477b7200c90d48f87081e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_751554b7f33544a1bb7a64d4eda75953 |
| publicationDate | 2011-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SG-175463-A1 |
| titleOfInvention | Method for the differentiation of human adult stem cells into insulin-secreting cells |
| abstract | METHOD FOR THE DIFFERENTIATION OF HUMAN ADULT STEM CELLS INTOINSULIN-SECRETING CELLSDisclosed is a method for differentiating human adultstem cells into insulin-secreting cells. Human adult stemcells, isolated from the subcutaneous adipose tissues aroundthe eyes, are induced to differentiate into insulin-secretingcells in a medium in the presence of cytokines and growthfactors including B27 supplement, fibroblast growth factor-2,epidermal growth factor, nicotinamide, glucagon-like peptide-1, activin A, insulin-like growth factor, betacellulin, etc.,with a glucose shift from a high concentration to a lowconcentration. Having the ability to producing insulin and C-peptide at high levels, the insulin-secreting cells can beexcellent curatives for type 1 diabetes mellitus.Figure 2 |
| priorityDate | 2010-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.